Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 20 - 85 |
| Updated: | 4/2/2016 |
| Start Date: | June 2012 |
| End Date: | January 2018 |
| Contact: | J Kevin DeMarco, MD |
| Email: | jkd@rad.msu.edu |
| Phone: | 517-88-3349 |
To compare two competing newly designed 3D sequences for black blood carotid plaque imaging
techniques with the industry standard 2D sequnce for black blood.
techniques with the industry standard 2D sequnce for black blood.
To utilize a 3D sequence instead of the usual 2D commonly standard industry sequence that is
supplied by the various manufacturers.
Patients with greater than 50% stenosis that are 3T compatible are imaged using the two
sequences to compare which sequences better visualize the plaque and it's characteristics
The purpose is to validate the ability of the new 3D sequence to detect and measure any
plaque hemorrhage as well as to identify region sof Type 1 hemorrhage.
supplied by the various manufacturers.
Patients with greater than 50% stenosis that are 3T compatible are imaged using the two
sequences to compare which sequences better visualize the plaque and it's characteristics
The purpose is to validate the ability of the new 3D sequence to detect and measure any
plaque hemorrhage as well as to identify region sof Type 1 hemorrhage.
Inclusion Criteria:
- Patients with 50% stenosis of the carotid arteries that are safe to undergo MRI
imaging
Exclusion Criteria:
- Patients that are determined to no be safe to undergo MR imaging due to implants
We found this trial at
1
site
Click here to add this to my saved trials
